文献速递中枢神经肿瘤放疗姑息放疗与转移瘤

运动皮质区脑转移瘤局部治疗后的早期运动功能:立体定向放疗/放射外科与显微手术切除的两队列回顾性研究

Early motor function after local treatment of brain metastases in the motor cortex region with stereotactic radiotherapy/radiosurgery or microsurgical resection: a retrospective study of two consecutive cohorts.
PubMed 文献 · Radiat Oncol · 2017-11-13

该回顾性研究比较了运动皮质区脑转移瘤经电生理监测下显微手术切除(MSR)与立体定向放疗/放射外科(SRT/SRS)治疗后的功能结局。共纳入27例MSR和41例SRT/SRS。MSR组治疗前后上下肢肌力均显著低于SRT/SRS组;SRT/SRS组肌力无变化,MSR组下肢肌力显著改善(p=0.05),上肢改善不显著。MSR对偏瘫的改善显著优于放疗,但术后肌力恶化更明显(改善p=0.04,恶化p=0.10)。结论:电生理引导下中央区转移瘤显微手术在偏瘫功能结局上显著更优,但SRT/SRS有次要神经功能恶化更少的趋势。

要点

  • MSR组治疗前后上下肢肌力均显著低于SRT/SRS组。
  • SRT/SRS组肌力无变化,MSR组下肢肌力显著改善(p=0.05)。
  • MSR对偏瘫改善显著优于放疗,但术后肌力恶化更明显(改善p=0.04,恶化p=0.10)。

核心结论

  • 电生理引导下中央区转移瘤显微手术在偏瘫功能结局上显著优于SRT/SRS。
  • SRT/SRS有次要神经功能恶化更少的趋势。

研究设计与样本

  • 回顾性研究,比较运动皮质区脑转移瘤的MSR与SRT/SRS两种治疗。
  • 数据来自2008年1月至2012年9月两个临床登记库:神经外科术中神经监测登记库和放疗科SRT/SRS前瞻性数据库。
  • 共纳入68例治疗,其中MSR 27例,SRT/SRS 41例。

主要发现

  • MSR组治疗前后上下肢肌力均显著低于SRT/SRS组。
  • SRT/SRS组 extremities 肌力无变化。
  • MSR组下肢肌力显著改善(p=0.05),上肢改善不显著。
  • MSR对偏瘫的改善显著优于放疗(p=0.04),但术后肌力恶化较SRT/SRS更明显(p=0.10)。

临床怎么用

  • 对于运动皮质区脑转移瘤,选择MSR可能更有利于偏瘫改善,但需权衡术后肌力恶化风险。
  • SRT/SRS可能减少次要神经功能恶化,适合作为功能保留优先的选项。

局限性

  • 回顾性研究,样本量较小(MSR 27例,SRT/SRS 41例)。
  • 数据来自两个不同登记库,可能存在选择偏倚和信息偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We compared the functional outcome and influential factors of two standard treatment modalities for central cerebral metastases: electrophysiological-controlled microsurgical resection (MSR) and stereotactic radiotherapy/stereotactic radiosurgery (SRT/SRS). METHODS: We performed a database search for central metastasis treatments during the period from January 2008 to September 2012 in two clinical registers: 1) register for intraoperative neuromonitoring (Department of Neurosurgery), and 2) prospective database for SRT/SRS (Department of Radiotherapy). Neurological status before and after treatment, Karnofsky performance index (KPI), histology, tumor localization and volume, and oncological status were standardized and pooled together for analysis. Muscle strength was graded on a scale of 0-5. RESULTS: We identified 27 MSR and 41 SRT/SRS cases from 68 treatments. The MSR-treated patients had significant less muscle strength in the upper and lower extremities before and after the treatment as compared to the patients receiving SRT/SRS. Muscle strength of the extremities did not change for patients receiving SRT/SRS, while MSR patients had significant improvement in lower extremity muscle strength (p = 0.05) and a non-significant improvement in the upper extremities. MSR showed significant improvement in hemiparesis as compared to radiotherapy, but this was accompanied with a significant deterioration of extremity muscle strength after surgery, as compared to SRT/SRS (improvement p = 0.04, deterioration p = 0.10). CONCLUSION: Electrophysiologically guided microsurgery of central metastases had a significantly better functional outcome regarding hemiparesis. However, there was also a trend for less secondary neurological deterioration after SRT/SRS. TRIAL REGISTRATION: ISRCTN81776764. Retrospectively Registered 27 July 2017.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Pintea B, Baumert B, Kinfe TM, et al. Early motor function after local treatment of brain metastases in the motor cortex region with stereotactic radiotherapy/radiosurgery or microsurgical resection: a retrospective study of two consecutive cohorts. Radiat Oncol. 2017. PMID: 29132382. doi:10.1186/s13014-017-0917-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。